4//SEC Filing
Vanston David Cecil 4
Accession 0001078782-19-000927
CIK 0000093314other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 11:53 AM ET
Size
8.0 KB
Accession
0001078782-19-000927
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Vanston David Cecil
Chief Financial Officer
Transactions
- Award
Option (Right to Buy)
2019-12-16+66,533→ 100,000 totalExercise: $5.00From: 2019-12-16Exp: 2023-04-10→ Common Stock (66,533 underlying) - Disposition to Issuer
Option (Right to Buy)
2019-12-16−66,533→ 33,467 totalExercise: $5.00From: 2018-04-10Exp: 2023-04-10→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The reported transactions involved a cancellation and reissuance of a portion of outstanding options upon agreement of the reporting person. The "old" options were originally granted on April 10, 2017 and vested in full at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The "replacement" options are fully-vested on the date of grant and have the same expiration date and exercise price as the "old" options.
Documents
Issuer
VOLITIONRX LTD
CIK 0000093314
Entity typeother
Related Parties
1- filerCIK 0001703012
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 11:53 AM ET
- Size
- 8.0 KB